Description
A PHGDH inhibitor that blocks serine synthesis from 3-phosphoglycerate in cells (IC50 = 2.5 µM); reduces the production of glucose-derived serine in cells and suppresses the growth of PHGDH-dependent MDA-MB-468 cancer cells both in vitro and in mice bearing orthotopic xenograft tumors
Formal name: N-(4,6-dimethyl-2-pyridinyl)-4-[[4-(trifluoromethyl)phenyl]methyl]-1-piperazinecarbothioamide
Synonyms:
Molecular weight: 408.5
CAS: 1916571-90-8
Purity: ≥98%
Formulation: A neat solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer